562(top 1%)
papers
38.0K(top 0.1%)
citations
100(top 0.1%)
h-index
178(top 0.1%)
g-index
658
all documents
41.7K
doc citations
2.9K
citing journals

Top Articles

#TitleJournalYearCitations
1Selective inhibition of BET bromodomainsNature20103,456
2The use of differential scanning fluorimetry to detect ligand interactions that promote protein stabilityNature Protocols20072,069
3Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell20121,368
4Epigenetic protein families: a new frontier for drug discoveryNature Reviews Drug Discovery20121,161
5Targeting bromodomains: epigenetic readers of lysine acetylationNature Reviews Drug Discovery20141,044
6Toward a unified nomenclature for mammalian ADP-ribosyltransferasesTrends in Biochemical Sciences2010724
7The promise and peril of chemical probesNature Chemical Biology2015698
8Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determinationProceedings of the National Academy of Sciences of the United States of America2006526
9Self-renewal as a therapeutic target in human colorectal cancerNature Medicine2014438
10Large-Scale Structural Analysis of the Classical Human Protein Tyrosine PhosphatomeCell2009421
11Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitorsNature Biotechnology2012410
12Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growthNature2015386
13Bromodomains as therapeutic targetsExpert Reviews in Molecular Medicine2011368
14Small-Molecule Inhibition of BRDT for Male ContraceptionCell2012353
15A systematic interaction map of validated kinase inhibitors with Ser/Thr kinasesProceedings of the National Academy of Sciences of the United States of America2007342
16Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategyNature2014336
17The bromodomain interaction moduleFEBS Letters2012325
18Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificityNature2007297
19Dual kinase-bromodomain inhibitors for rationally designed polypharmacologyNature Chemical Biology2014296
20A roadmap to generate renewable protein binders to the human proteomeNature Methods2011277
21The (un)targeted cancer kinomeNature Chemical Biology2010267
22A Strategy for Modulation of Enzymes in the Ubiquitin SystemScience2013257
23Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding SitesJournal of Medicinal Chemistry2012254
24BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histonesNature Structural and Molecular Biology2014247
25Structure and Biochemical Functions of SIRT6Journal of Biological Chemistry2011239
26Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor developmentFuture Medicinal Chemistry2010236
27Crystal structure of the CorA Mg2+ transporterNature2006233
28Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural DevelopmentCell2012227
29The ins and outs of selective kinase inhibitor developmentNature Chemical Biology2015220
30Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase InhibitorsJournal of the American Chemical Society2011218
31Sgf29 binds histone H3K4me2/3 and is required for SAGA complex recruitment and histone H3 acetylationEMBO Journal2011218
32Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organismsMolecular and Biochemical Parasitology2007216
33Rapid Covalent-Probe Discovery by Electrophile-Fragment ScreeningJournal of the American Chemical Society2019213
34A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine MethyltransferasesACS Chemical Biology2016208
353,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain LigandsJournal of Medicinal Chemistry2011204
36An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating EnzymeCell2011203
37Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target EngagementCell Chemical Biology2018197
38Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapyCancer Research2015193
39A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron densityNature Communications2017186
40SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control terminationNature2016185
41Carbonyl Reductases: The Complex Relationships of Mammalian Carbonyl- and Quinone-Reducing Enzymes and Their Role in PhysiologyAnnual Review of Pharmacology and Toxicology2007184
42Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived HitJournal of Medicinal Chemistry2012184
43Structural Analysis Identifies Imidazo[1,2-b]Pyridazines as PIM Kinase Inhibitors with In vitro Antileukemic ActivityCancer Research2007183
44MOF and H4 K16 Acetylation Play Important Roles in DNA Damage Repair by Modulating Recruitment of DNA Damage Repair Protein Mdc1Molecular and Cellular Biology2010181
45Structural basis and specificity of human otubain 1-mediated deubiquitinationBiochemical Journal2009180
46Structural basis for the allosteric inhibitory mechanism of human kidney-type glutaminase (KGA) and its regulation by Raf-Mek-Erk signaling in cancer cell metabolismProceedings of the National Academy of Sciences of the United States of America2012178
47Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines.Journal of Medicinal Chemistry2010177
48Structural diversity in the RGS domain and its interaction with heterotrimeric G protein α-subunitsProceedings of the National Academy of Sciences of the United States of America2008174
49The Crystal Structure of the Human Toll-like Receptor 10 Cytoplasmic Domain Reveals a Putative Signaling DimerJournal of Biological Chemistry2008171
50EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialLancet, The2014171